Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore.
Publication
, Journal Article
Hung, S-I; Chung, W-H
Published in: Neurology
April 23, 2013
Duke Scholars
Published In
Neurology
DOI
EISSN
1526-632X
Publication Date
April 23, 2013
Volume
80
Issue
17
Start / End Page
1621
Location
United States
Related Subject Headings
- Neurology & Neurosurgery
- Male
- Humans
- HLA-B15 Antigen
- Genetic Testing
- Female
- Epilepsy
- Decision Making
- 3209 Neurosciences
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Hung, S.-I., & Chung, W.-H. (2013). Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore. Neurology, 80(17), 1621. https://doi.org/10.1212/WNL.0b013e3182915be2
Hung, Shuen-Iu, and Wen-Hung Chung. “Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore.” Neurology 80, no. 17 (April 23, 2013): 1621. https://doi.org/10.1212/WNL.0b013e3182915be2.
Hung S-I, Chung W-H. Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore. Neurology. 2013 Apr 23;80(17):1621.
Hung, Shuen-Iu, and Wen-Hung Chung. “Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore.” Neurology, vol. 80, no. 17, Apr. 2013, p. 1621. Pubmed, doi:10.1212/WNL.0b013e3182915be2.
Hung S-I, Chung W-H. Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore. Neurology. 2013 Apr 23;80(17):1621.
Published In
Neurology
DOI
EISSN
1526-632X
Publication Date
April 23, 2013
Volume
80
Issue
17
Start / End Page
1621
Location
United States
Related Subject Headings
- Neurology & Neurosurgery
- Male
- Humans
- HLA-B15 Antigen
- Genetic Testing
- Female
- Epilepsy
- Decision Making
- 3209 Neurosciences
- 3202 Clinical sciences